Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models.
about
Prognostic Genetic Signatures in Upper Tract Urothelial CarcinomaPTEN deficiency is associated with reduced sensitivity to mTOR inhibitor in human bladder cancer through the unhampered feedback loop driving PI3K/Akt activationClinical significance of increased expression of Nijmegen breakage syndrome gene (NBS1) in human primary liver cancerMolecular Analysis of Upper Tract and Bladder Urothelial Carcinoma: Results from a Microarray ComparisonMammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma.Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladderBirt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.Guidelines for the welfare and use of animals in cancer research.Exploration of the postponing mechanism that delays carcinoma onset.The genomic landscape of oesophagogastric junctional adenocarcinoma.Role of the mTOR Pathway in the Progression and Recurrence of Bladder Cancer: An Immunohistochemical Tissue Microarray Study.Is 5´-AMP-Activated Protein Kinase Both Jekyll and Hyde in Bladder Cancer?Genetic deletion and pharmacological inhibition of Akt1 isoform attenuates bladder cancer cell proliferation, motility and invasion.SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy.MicroRNA-214 Reduces Insulin-like Growth Factor-1 (IGF-1) Receptor Expression and Downstream mTORC1 Signaling in Renal Carcinoma Cells.Dysregulation of mammalian target of rapamycin pathway in plasmacytoid variant of urothelial carcinoma of the urinary bladderHsa-miR-137, hsa-miR-520e and hsa-miR-590-3p perform crucial roles in Lynch syndrome.The mechanisms of malic enzyme 2 in the tumorigenesis of human gliomas.Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway.Exploring molecular genetics of bladder cancer: lessons learned from mouse modelsOrthotopic mouse model of renal pelvic cancer using a human bladder cancer cell line.Ochratoxin A activates opposing c-MET/PI3K/Akt and MAPK/ERK 1-2 pathways in human proximal tubule HK-2 cells.The role of WNT signalling in urothelial cell carcinoma.EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop.Aged black garlic extract inhibits HT29 colon cancer cell growth via the PI3K/Akt signaling pathway.Overexpression of DJ-1 and HSP90α, and loss of PTEN associated with invasive urothelial carcinoma of urinary bladder: Possible prognostic markers.Effect of orthodontic force on the expression of PI3K, Akt, and P70S6 K in the human periodontal ligament during orthodontic loading.Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder.Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.
P2860
Q26772220-25215DDD-94F4-4EE3-9019-2BF5F331D64BQ27852528-E5669D33-CFFA-44F9-9727-93C4E7E2E6CBQ28265438-6CE1AAF8-EE79-4F25-BC56-72825FD95737Q28547625-F43E758E-B706-4596-A30F-60ACAFBD337CQ30432032-B1FE3C22-5E1A-4C1C-9A33-63D116C9955FQ33772260-FEFD419A-905E-494B-9722-9E86E04416A6Q33772820-F4C2B5F2-DDFF-4974-AB2E-4B6F40203CA8Q33903753-C5CB6E39-AC50-4B1C-81FC-38D446B5D210Q34273627-0403C8B5-3AE7-4128-B946-827CAB288213Q34389892-FEC9E89D-C147-41C9-BC60-8934587ABF29Q35151995-33B309D1-7301-4313-88A1-EDB71449FE2FQ35813290-CE34404A-7654-40A7-8C45-EBA05E1A34EEQ36144821-D06F7EE9-F7AD-4B85-B553-1AA30E4E07E0Q36567906-E121EF92-015F-4A92-99CB-068B5964D36EQ36598752-200A1249-779D-40B1-984A-BADD152A207EQ37078685-0709041F-3B7E-4CFB-A2A5-2AC2D022E0B0Q37091474-731AD04A-6818-4054-9DEB-4708663A304FQ37206009-FB350E6C-56E5-4E95-ABD5-2CEABB47E153Q37520257-38579654-0AF4-4A99-9BD1-FE09D63791DAQ37775890-1FBC83CB-1E6F-4A2C-90CA-FE1208263B0CQ37994164-16C8D2C8-8264-464B-ABF3-75920683EEB1Q38736864-71A3345C-AF9C-4E9B-8D63-F1FD1A9C5A19Q38977350-2EC2BF12-27A2-4868-93C6-2A9E308020CCQ40642338-865AF9BE-47AA-4CEC-A6B0-CD2A5DB7C5DCQ41122951-8B2F6F74-0D2D-4384-9C49-EC737DFD82DFQ41878307-F4077EC2-5153-4986-B3CC-3EF161520765Q41984466-B83CE95C-46DC-4926-AF83-2F428FAD7BDCQ47889942-B24A1A8F-BDB0-4BDC-BD06-2AE0CF1E58B8Q48839946-DC85CBF0-F43F-4355-9B64-13EE83FEF253Q49795695-B94F6C85-0FE7-4C14-BB69-C4AC90FBEF30
P2860
Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Activation of the PI3K/AKT pat ...... confirmation in animal models.
@ast
Activation of the PI3K/AKT pat ...... confirmation in animal models.
@en
Activation of the PI3K/AKT pat ...... confirmation in animal models.
@nl
type
label
Activation of the PI3K/AKT pat ...... confirmation in animal models.
@ast
Activation of the PI3K/AKT pat ...... confirmation in animal models.
@en
Activation of the PI3K/AKT pat ...... confirmation in animal models.
@nl
prefLabel
Activation of the PI3K/AKT pat ...... confirmation in animal models.
@ast
Activation of the PI3K/AKT pat ...... confirmation in animal models.
@en
Activation of the PI3K/AKT pat ...... confirmation in animal models.
@nl
P2093
P2860
P50
P1433
P1476
Activation of the PI3K/AKT pat ...... confirmation in animal models.
@en
P2093
Aaron Massie
Annick Vieillefond
Chao-Nan Qian
Eric J Kort
Eva Comperat
Hans Morreau
James H Resau
Jared Knol
Jindong Chen
P2860
P304
P356
10.1158/0008-5472.CAN-09-1689
P407
P577
2009-10-20T00:00:00Z